- Home
- TPG vs BCPC Comparison
TPG vs BCPC Comparison
Compare TPG & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TPG | BCPC |
|---|---|---|
| Founded | 1992 | 1967 |
| Country | United States | United States |
| Employees | 1900 | N/A |
| Industry | Investment Managers | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 5.6B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | TPG | BCPC |
|---|---|---|
| Price | $42.44 | $157.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 2 |
| Target Price | $61.20 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 2.0M | 142.9K |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.89% | 0.55% |
| EPS Growth | N/A | ★ 20.87 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $799,023,000.00 |
| Revenue This Year | N/A | $8.47 |
| Revenue Next Year | $19.79 | $4.89 |
| P/E Ratio | ★ $106.82 | $125.30 |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $36.95 | $139.17 |
| 52 Week High | $70.38 | $183.90 |
Technical Indicators
Market Signals| Indicator | TPG | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 50.22 | 32.87 |
| Support Level | $41.43 | $150.49 |
| Resistance Level | $46.61 | $159.54 |
| Average True Range (ATR) | 1.50 | 3.21 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 57.45 | 32.80 |
Price Performance
Historical ComparisonAbout TPG TPG Inc.
TPG Inc is an alternative asset management firm. It invests across five multi-product platforms, namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company invests across a broadly diversified set of strategies, including private equity, impact, credit, real estate, market solutions, innovation, and inclusion.
About BCPC Balchem Corporation
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.